Sialic acid-binding immunoglobulin-like lectins (Siglecs) recognize sialylated glycoconjugates and play a role in cell-cell recognition. Siglec-7 is expressed on natural killer cells and displays unique ligand binding properties different from other members of the Siglec family. Here we describe the high resolution structures of the N-terminal V-set Ig-like domain of Siglec-7 in two crystal forms, at 1.75 and 1.9 Å. The latter crystal form reveals the full structure of this domain and allows us to speculate on the differential ligand binding properties displayed by members of the Siglec family. A fully ordered N-linked glycan is observed, tethered by tight interactions with symmetry-related protein molecules in the crystal. Comparison of the structure with that of sialoadhesin and a model of Siglec-9 shows that the unique preference of Siglec-7 for ␣(2,8)-linked disialic acid is likely to reside in the C-C loop, which is variable in the Siglec family. In the Siglec-7 structure, the ligandbinding pocket is occupied by a loop of a symmetryrelated molecule, mimicking the interactions with sialic acid.The Siglecs 1 are a specialized subgroup of the Ig superfamily that share significant sequence similarity and the ability to recognize sialylated glycoconjugates (1). There are at least 11 bona fide members in humans and potentially 8 in mice, all of which are type 1 membrane proteins, containing an N-terminal sialic acid-binding V-set Ig domain and varying numbers of C2-set Ig domains (2). Apart from myelin-associated glycoprotein (MAG, Siglec-4), which is found uniquely in the nervous system, Siglecs are expressed predominantly in the hemopoietic and immune systems and appear to mediate both adhesive and signaling functions (3).Siglecs can be divided into two subgroups based on sequence similarity in the extracellular and intracellular regions. Sialoadhesin (Siglec-1), CD22 (Siglec-2), and MAG constitute one subgroup, share ϳ25-30% sequence identity in the extracellular region, and have divergent cytoplasmic tails. The second subgroup is made up of the CD33-related Siglecs that include CD33 (Siglec-3) and the recently discovered human Siglecs 5-11 (reviewed in Ref.3). These proteins share 50 -80% sequence similarity and have two highly conserved tyrosinebased motifs in their cytoplasmic tails. In humans, the CD33-related Siglec genes are clustered on chromosome 19q13.3-4 and are separate from the genes encoding CD22, MAG (19q13.1), and sialoadhesin (20p). Recent studies using specific monoclonal antibodies have shown that the CD33-related Siglecs are expressed in a partially overlapping manner on all major leukocytes of the innate immune system, suggesting a role for these proteins in regulation of leukocyte function. This is further supported by the finding that human CD33-related Siglecs have two conserved immunoreceptor tyrosine-based inhibitory motif-like sequences, which in all cases studied can interact with the tyrosine phosphatases SHP-1 and SHP-2 following tyrosine phosphorylation (4 -8). Recent studies of C...